MICHAEL D. KAUFMAN,DANIEL L FLYNN,YU MI AHN,LAKSHMINARAYANA VOGETI,TIMOTHY MALCOLM CALDWELL
申请号：
PT14764032
公开号：
PT2968286T
申请日:
2014.03.14
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
